Socioeconomic status and risk factors for complications in young people with type 1 or type 2 diabetes: a cross-sectional study.
diabetes mellitus
poverty
type 2
young adult
Journal
BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
16
07
2021
accepted:
26
11
2021
entrez:
31
12
2021
pubmed:
1
1
2022
medline:
24
3
2022
Statut:
ppublish
Résumé
Young people with type 2 diabetes (T2D) develop complications earlier than those with type 1 diabetes (T1D) of comparable duration, but it is unclear why. This apparent difference in phenotype could relate to relative inequality. Cross-sectional study of young people referred to secondary diabetes services in Auckland, Aotearoa-New Zealand (NZ): 731 with T1D and 1350 with T2D currently aged Young people with T2D were an average 3 years older than those with T1D but had a similar duration of diabetes. 71% of those with T2D were of Māori or Pasifika descent, compared with 24% with T1D (p<0.001). T1D cases were distributed evenly across NZDep categories. 78% of T2D cases were living in the lowest four NZDep categories (p<0.001). In both diabetes types, body mass index (BMI) increased progressively across the NZDep spectrum (p<0.002), as did mean glycated hemoglobin (HbA The apparent more aggressive phenotype of young-onset T2D is at least in part explicable by relative deprivation.
Identifiants
pubmed: 34969690
pii: 9/2/e002485
doi: 10.1136/bmjdrc-2021-002485
pmc: PMC8719138
pii:
doi:
Substances chimiques
Glycated Hemoglobin A
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Pediatr Diabetes. 2019 Nov;20(7):821-831
pubmed: 31329349
Diabetes Care. 2014 Feb;37(2):436-43
pubmed: 24130346
Diabet Med. 2015 Mar;32(3):295-304
pubmed: 25381964
J Clin Endocrinol Metab. 2011 Jan;96(1):159-67
pubmed: 20962021
Nat Rev Endocrinol. 2020 Jun;16(6):321-331
pubmed: 32203408
Lancet. 2017 Jun 3;389(10085):2252-2260
pubmed: 28589895
Paediatr Child Health. 2007 Oct;12(8):693-7
pubmed: 19030448
Diabetes Res Clin Pract. 2014 Jan;103(1):63-70
pubmed: 24380605
Am J Public Health. 2003 Feb;93(2):277-84
pubmed: 12554585
Diabetes Care. 2010 Jun;33(6):1347-52
pubmed: 20299482
JAMA. 2017 Feb 28;317(8):825-835
pubmed: 28245334
Diabetologia. 2021 Aug;64(8):1709-1716
pubmed: 34075436
J Paediatr Child Health. 2004 Apr;40(4):201-4
pubmed: 15009549
JAMA. 2014 May 7;311(17):1778-86
pubmed: 24794371
J Adolesc Health. 2016 Sep;59(3):354-361
pubmed: 27426206
Can J Public Health. 2012 May 09;103(8 Suppl 2):S7-11
pubmed: 23618071
Diabetes Care. 2019 Oct;42(10):1895-1902
pubmed: 31221678
Diabetes Care. 2016 May;39(5):823-9
pubmed: 27006511
Pediatr Diabetes. 2012 Jun;13(4):294-300
pubmed: 22646236
Lancet. 2017 Oct 21;390(10105):1829
pubmed: 29082873
Diabetes Care. 2020 May;43(5):975-981
pubmed: 32132007
Soc Sci Med. 2006 Mar;62(6):1474-85
pubmed: 16154674
Pediatr Diabetes. 2016 Jun;17(4):266-73
pubmed: 25951940
Health Place. 2014 Sep;29:10-7
pubmed: 24945103
Lancet. 2011 Aug 27;378(9793):804-14
pubmed: 21872749
Diabetes Care. 2021 Sep;44(9):1938-1947
pubmed: 34131048
BMJ Open Diabetes Res Care. 2017 Aug 11;5(1):e000412
pubmed: 28878938
Am J Epidemiol. 1978 Dec;108(6):497-505
pubmed: 736028
Intern Med J. 2018 Jun;48(6):728-731
pubmed: 29898267
Res Social Adm Pharm. 2019 Jun;15(6):744-753
pubmed: 30241872
Curr Diabetes Rev. 2018;14(4):321-326
pubmed: 28637406
Diabetes Care. 2013 Dec;36(12):3863-9
pubmed: 23846814
Lancet Diabetes Endocrinol. 2014 May;2(5):417-26
pubmed: 24795255
Lancet Public Health. 2017 Aug;2(8):e356-e366
pubmed: 29253477